EXECUTIVE LEADERSHIP SERIES
ASHTON TWEED'S EXECUTIVE INTERVIEWS
July 5, 2023
Mohamed Ladha President and General Manager Recordati Rare Diseases North America When Mohamed Ladha joined Recordati Rare Diseases a year ago to run its North American […]
May 9, 2023
Edward (Ned) F. Patz Jr., M.D CEO Grid Therapeutics, LLC When Dr. Edward (Ned) Patz Jr. co-founded Grid Therapeutics in 2016, he had discovered a novel, […]
April 6, 2023
Maria L. Maccecchini Ph.D., President and CEO Annovis Bio In the past 20 years, researchers have made little headway in developing an effective treatment for Alzheimer’s […]
October 10, 2022
Wamis Singhatat, CEO ActiveProtective Technologies Inc. Falling and breaking a hip is a perpetual fear for older people and their families. A hip fracture can result […]
July 24, 2022
Paul Joyce, CEO Orthotic Holdings Inc. Before he accepted the CEO position at Orthotic Holdings Inc. (OHI), Paul Joyce had no idea he was using an […]
September 29, 2021
April 6, 2021
Nicholas Hart President and CEO of Ascend Therapeutics When Nicholas Hart joined Ascend Therapeutics, a pharmaceutical company specializing in women’s health, in January 2020, he was […]
January 14, 2021
Marco Taglietti, M.D. President and CEO of Scynexis When Marco Taglietti, M.D., decided to retire in 2014 at age 55, it was after a long and […]
November 9, 2020
When Susan Dillon co-founded Aro Biotherapeutics in 2018, she had already led teams of researchers at Johnson & Johnson to develop revolutionary drugs for autoimmune diseases—Remicade®, Simponi, Stelara® and Tremfya®.
October 2, 2020
HOW TO SUCCEED WITH A PHARMA STARTUP WHEN YOU’RE ON YOUR OWN Dr. Jie Du had a unique problem when it came to fundraising for her […]
August 21, 2020
DEVELOPING A NOVEL SOLUTION FOR A GROWING PROBLEM A drug crisis has been quietly growing that many people may not be aware of—the abuse of stimulant […]
July 10, 2020
May 31, 2020
April 27, 2020
PERSONAL INVESTMENT HELPS DRIVE NEW CANCER THERAPY DEVELOPMENT When Stella Vnook became CEO of Diverse Biotech Inc. in mid-2019, she welcomed the challenge of guiding the […]
January 24, 2020
CHANGING THE PARADIGM OF CANCER DIAGNOSIS When Suman Shirodkar, MBBS, Ph.D., became the CEO of Cambridge Epigenetix Ltd. in 2018, she brought several decades of diverse […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406